Infectologia
[Preprint] Covid longa: revisão sistemática e metanálise de 120.970 pacientes.
16 Mai, 2022 | 16:41hLong Covid: A Systematic Review and Meta-Analysis of 120,970 Patients – Preprints with The Lancet
Comentário no Twitter
A systematic #LongCovid review of nearly 200 studies and over 120,000 participants, reinforces the high frequency of symptoms > 6 months, not linked to severity of acute illness, and potential for marked disabilityhttps://t.co/9NYQT1P79G pic.twitter.com/WFzBqghbGI
— Eric Topol (@EricTopol) May 6, 2022
Características clínicas e fatores de risco de COVID-19 grave ou fatal entre pessoas internadas que vivem com HIV: análise de dados da WHO Global Clinical Platform of COVID-19.
16 Mai, 2022 | 16:39hComentário convidado: A collision of pandemics: HIV and COVID-19 – The Lancet HIV
Comentários no Twitter
New: Clinical features of, and risk factors for, severe or fatal COVID-19 among people living with HIV admitted to hospital: analysis of data from the WHO Global Clinical Platform of COVID-19 by Silvia Bertagnolio and colleagues https://t.co/hAyuWi7fMN #openaccess pic.twitter.com/VmjeYMLPHu
— The Lancet HIV (@TheLancetHIV) May 11, 2022
Clinical features of, and risk factors for, severe or fatal COVID-19 among PLWH admitted to hospital…. https://t.co/KKVKwroy4Z Compared with individuals without HIV, PLWH (96% living in Africa) had 15% ⬆️ odds of severe COVID-19 and were 38% more likely to die in hospital.
— Carlos del Rio (@CarlosdelRio7) May 12, 2022
Infecções esqueléticas: patogênese microbiológica, imunidade e tratamento clínico.
16 Mai, 2022 | 16:29hSkeletal infections: microbial pathogenesis, immunity and clinical management – Nature Reviews Microbiology (se o acesso a este link for pago, tente este)
Revisão liderada por farmacêuticos pode melhorar as prescrições de antibióticos na alta hospitalar.
16 Mai, 2022 | 16:25hComentário: Pharmacist-led review tied to better antimicrobial prescribing at discharge – CIDRAP
Estudo original: Pharmacist-Driven Transitions of Care Practice Model for Prescribing Oral Antimicrobials at Hospital Discharge – JAMA Network Open
Disparidades étnicas na estimativa de excesso de mortalidade por causas externas nos EUA, de março a dezembro/2020.
16 Mai, 2022 | 16:24hRacial and Ethnic Disparities in Estimated Excess Mortality From External Causes in the US, March to December 2020 – JAMA Internal Medicine (gratuito por tempo limitado)
Comentário no Twitter
In this study, American Indian or Alaska Native and Black populations experienced high rates or excess deaths from external causes (transportation fatalities homicide, and drug-related deaths) during the early #COIVD19 pandemic. https://t.co/RaatdoaFzI
— JAMA Internal Medicine (@JAMAInternalMed) May 11, 2022
Revisão sistemática | Antibioticoprofilaxia na prevenção de endocardite bacteriana após procedimentos dentários.
13 Mai, 2022 | 12:56h
Comentário no Twitter
Have a look at the evidence on antibiotics for preventing bacterial endocarditis in people undergoing dental treatment. Summary here: https://t.co/7uxnkbgt8t. Full review here: https://t.co/3Au3EsHZIU pic.twitter.com/RLsF3fHiZa
— Cochrane Oral Health (@CochraneOHG) May 11, 2022
Estudo randomizado | Avaliação da vacina de mRNA-1273 contra Covid-19 em crianças de 6 a 11 anos de idade.
13 Mai, 2022 | 12:55h
Comentário no Twitter
Two 50-μg doses of mRNA-1273 vaccine were found to be safe and effective in inducing immune responses and preventing Covid-19 in children 6 to 11 years of age. https://t.co/A5SBK4zK6E pic.twitter.com/7x4JgOwK57
— NEJM (@NEJM) May 11, 2022
Inibição de capsídio com lenacapavir na infecção pelo HIV-1 multirresistente.
13 Mai, 2022 | 12:53hCapsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection – New England Journal of Medicine (link para o resumo – $ para o texto completo)
Comentário: Lenacapavir for HIV Infection in a Multidrug-Resistant Study Cohort – ContagionLive
Atualização epidemiológica | Hepatite de origem desconhecida em crianças.
13 Mai, 2022 | 12:50hConteúdos relacionados:
Unexplained hepatitis cases in kids rise to 348 in 20 nations – CIDRAP
Multi-Country – Acute, severe hepatitis of unknown origin in children – World Health Organization
WHO says 12 countries have reported unusual cases of hepatitis in kids – STAT
Could Mysterious Hepatitis Cases be Triggered by COVID-19? – Health Policy Watch
U.S., U.K. investigating unusual cases of hepatitis in young children – STAT
Mysterious liver illness seen in kids in US, Europe – Associated Press
Comentário no Twitter (fio – clique para saber mais)
Update: #Hepatitis of unknown aetiology in children – 11 May 2022
Approximately 106 cases have been identified in 14 EU/EEA countries and 450 cases are reported worldwide.
The cause of the disease is still under investigation.
Read more: https://t.co/B0lLm7I0dV— ECDC Outbreaks (@ECDC_Outbreaks) May 11, 2022